FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to the pharmaceutical industry and is a composition for inducing and maintaining food ketosis comprising at least one medium chain acid or an ester thereof in an amount of 5 to 50 g, and at least one beta-hydroxybutyrate compound in an amount of 2 to 50 g, which comprises at least one salt of beta hydroxybutyrate.
EFFECT: invention provides a significant improvement in the performance of metabolic biomarkers associated with insulin resistance, diabetes, weight loss and physical performance in a short period of time, leads to a statistically significant increase in the blood ketone level and a decrease blood glucose level, does not adversely affect the lipid profile.
30 cl, 5 ex, 6 tbl, 14 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| KETOGENIC COMPOSITION | 2021 |
|
RU2769242C1 |
| PREVENTION AND TREATMENT OF MIGRAINE | 2017 |
|
RU2753057C2 |
| TREATMENT OF TRAUMATIC BRAIN INJURY | 2018 |
|
RU2771277C2 |
| METHODS AND COMPOSITIONS FOR INCREASING CONTENT OF KETONE BODIES IN ANIMALS | 2019 |
|
RU2786226C2 |
| COMPOSITION FOR USE IN THE TREATMENT OF EPILEPSY | 2018 |
|
RU2793246C2 |
| THERAPEUTIC COMPOSITIONS (U) | 1999 |
|
RU2242227C2 |
| ESTERS OF BETA-HYDROXYBUTYRATE AND BUTANEDIOL FORMED BY MEDIUM-CHAIN FATTY ACIDS AND COMPOSITIONS AND METHODS BASED ON THEM | 2017 |
|
RU2761829C2 |
| BEVERAGE PREPARATION PASTE | 2020 |
|
RU2826079C1 |
| KETOGENIC DIET | 2007 |
|
RU2433748C2 |
| ENERGY-METABOLIC COMPOSITION FOR PREVENTION AND TREATMENT OF KETOSIS AND FATTY HEPATOSIS IN COWS | 2017 |
|
RU2674682C2 |
